KIORA PHARMACEUTICALS INC — Investor Relations & Filings
Filings indexed
888
across all filing types
Latest filing
2026-05-28
Regulatory Filings
Country
US
United States of America
Listing
US
KPRX
Kiora Pharmaceuticals, Inc. is a clinical-stage company focused on developing advanced therapies for retinal diseases. The company's strategy is to target critical pathways underlying vision-threatening conditions using innovative small molecules. Its primary objective is to develop treatments that can slow, stop, or restore vision loss, with a particular focus on ophthalmic conditions that have limited or no effective therapies currently available.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 424B3 | 2026-05-28 | English | |
| S-3 | 2026-05-18 | English | |
| 8-K - KIORA PHARMACEUTICALS INC (0001372514) (Filer) | 2026-05-08 | English | |
| 10-Q - KIORA PHARMACEUTICALS INC (0001372514) (Filer) | 2026-05-08 | English | |
| ARS - KIORA PHARMACEUTICALS INC (0001372514) (Filer) | 2026-05-01 | English | |
| 8-K - KIORA PHARMACEUTICALS INC (0001372514) (Filer) | 2026-04-07 | English |
Browse filings by year
19 yearsMarket data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Irwin Naturals Inc.
Nutraceutical company distributing premium soft-gel supplem…
|
IWIN | CA | Manufacturing |
|
Ishita Drugs & Industries Ltd.
Produces APIs, drug intermediates, and folic acid for globa…
|
524400 | IN | Manufacturing |
|
Isodiol International Inc.
Develops and distributes hemp-based consumer goods and high…
|
ISOLF | CA | Manufacturing |
|
IsoTis S.A.
Specialized in proprietary orthobiologics products for the …
|
ISON | CA | Manufacturing |
|
ISU Abxis Co., Ltd.
Develops antibody-based immunotherapies for oncology and ra…
|
086890 | KR | Manufacturing |
|
Iterum Therapeutics plc
Develops and commercializes anti-infectives for multi-drug …
|
ITRM | US | Manufacturing |
|
IX BIOPHARMA LTD.
A specialty pharmaceutical and nutraceutical company develo…
|
42C | SG | Manufacturing |
|
Jacobio Pharmaceuticals Group Co., Ltd.
Biopharma specializing in innovative oncology therapies dis…
|
1167 | KY | Manufacturing |
|
Jacobson Pharma Corporation Limited
Leading regional pharmaceutical group specializing in the p…
|
2633 | HK | Manufacturing |
|
Jagsonpal Pharmaceuticals Limited
Develops and markets formulations for gynecology, orthopedi…
|
JAGSNPHARM | IN | Manufacturing |
KIORA PHARMACEUTICALS INC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35256/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35256 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35256 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35256 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35256}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for KIORA PHARMACEUTICALS INC (id: 35256)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.